Literature DB >> 19139948

Improved left ventricular function after transplantation of microspheres and fibroblasts in a rat model of myocardial infarction.

Alexander Schuh1, Elisa A Liehn, Alexander Sasse, Rebekka Schneider, Sabine Neuss, Christian Weber, Malte Kelm, Marc W Merx.   

Abstract

As a novel and promising therapeutic strategy for heart failure, the application of different cell types is the subject of increasing research interest. In this study we investigated the effect of several cell types and microspheres (uniform polystyrene microspheres, 10 microm diameter) transplanted 4 weeks after induction of myocardial infarction in a rat model. Eight weeks after intramyocardial application of fibroblasts and microspheres, left ventricular function was significantly improved as demonstrated by isolated heart studies (Langendorff) and echocardiographic findings (LVDP fibroblasts 129 +/- 32.9 mmHg, LVDP microspheres 119.2 +/- 24.1 mmHg, fractional shortening (FS) microspheres 38.9 +/- 4.6%, FS fibroblasts 36.84 +/- 6.05%) in contrast to injection of macrophages or medium alone (LVDP medium 67 +/- 22.6 mmHg, LVDP macrophages 75.9 +/- 24.8 mmHg, FS macrophages 29.16 +/- 8.7%, FS medium 27.2 +/- 7.2%, P < 0.05). Signals of Bromodesoxy-Uridine (BrdU) labeled transplanted fibroblasts were detected in infarcted areas. Microspheres were recorded abundantly by autofluorescence. Significantly more apoptotic cells were observed in infarcted areas of macrophage (328.6 +/- 37.4 cells/mm(2)) and medium (338.7 +/- 16.5 cells/mm(2); P < 0.05) treated hearts compared to microsphere (233.2 +/- 16.8 cells/mm(2)) and fibroblast (232.2 +/- 19.1 cells/mm(2)) injected hearts. Neovascularization, as reflected by the density of CD 31 positive vessels in the infracted area, did not differ between the four groups studied. The increased number of macrophages in infarcted areas after fibroblast and microsphere injection (fibroblasts 94.7 +/- 7.1 cells/mm(2), microspheres 82.2 +/- 3.0 cells/mm(2), macrophages 56.02 +/- 9.93 cells/mm(2), medium 46.35 +/- 9.03 cells/mm(2), P < 0.05) suggests that the underlying mechanism of augmented left ventricular function might be based on inflammatory processes.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19139948     DOI: 10.1007/s00395-008-0763-7

Source DB:  PubMed          Journal:  Basic Res Cardiol        ISSN: 0300-8428            Impact factor:   17.165


  11 in total

1.  Intracoronary administration of cardiac stem cells in mice: a new, improved technique for cell therapy in murine models.

Authors:  Qianhong Li; Yiru Guo; Qinghui Ou; Ning Chen; Wen-Jian Wu; Fangping Yuan; Erin O'Brien; Tao Wang; Li Luo; Gregory N Hunt; Xiaoping Zhu; Roberto Bolli
Journal:  Basic Res Cardiol       Date:  2011-04-24       Impact factor: 17.165

2.  The heme oxygenase 1 inducer (CoPP) protects human cardiac stem cells against apoptosis through activation of the extracellular signal-regulated kinase (ERK)/NRF2 signaling pathway and cytokine release.

Authors:  Chuanxi Cai; Lei Teng; Duc Vu; Jia-Qiang He; Yiru Guo; Qianghong Li; Xian-Liang Tang; Gregg Rokosh; Aruni Bhatnagar; Roberto Bolli
Journal:  J Biol Chem       Date:  2012-08-09       Impact factor: 5.157

3.  Intravenous and intramyocardial injection of apoptotic white blood cell suspensions prevents ventricular remodelling by increasing elastin expression in cardiac scar tissue after myocardial infarction.

Authors:  Michael Lichtenauer; Michael Mildner; Andrea Baumgartner; Matthias Hasun; Gregor Werba; Lucian Beer; Patrick Altmann; Georg Roth; Mariann Gyöngyösi; Bruno Karl Podesser; Hendrik Jan Ankersmit
Journal:  Basic Res Cardiol       Date:  2011-03-17       Impact factor: 17.165

4.  Myocardial regeneration by transplantation of modified endothelial progenitor cells expressing SDF-1 in a rat model.

Authors:  Alexander Schuh; Andreas Kroh; Simone Konschalla; Elisa A Liehn; Radoslav M Sobota; Erik Al Biessen; Ilze Bot; Tolga Taha Sönmez; Sönmez Tolga Taha; Andreas Schober; Nikolaus Marx; Christian Weber; Alexander Sasse
Journal:  J Cell Mol Med       Date:  2012-10       Impact factor: 5.310

5.  Repetitive transplantation of different cell types sequentially improves heart function after infarction.

Authors:  Schuh Alexander; Alexander Sasse; Simone Konschalla; Andreas Kroh; Marc W Merx; Christian Weber; Elisa A Liehn
Journal:  J Cell Mol Med       Date:  2012-07       Impact factor: 5.310

6.  Hypoxia training attenuates left ventricular remodeling in rabbit with myocardial infarction.

Authors:  Chun-Xiao Wan; Yun-Feng Lan; Hui Jiang; Jie Huang; Rui-Sheng Li; Sheng Bi; Jian-An Li
Journal:  J Geriatr Cardiol       Date:  2014-09       Impact factor: 3.327

7.  Application of peripheral-blood-derived endothelial progenitor cell for treating ischemia-reperfusion injury and infarction: a preclinical study in rat models.

Authors:  Zhi-Tang Chang; Lang Hong; Hong Wang; Heng-Li Lai; Lin-Feng Li; Qiu-Lin Yin
Journal:  J Cardiothorac Surg       Date:  2013-03-01       Impact factor: 1.637

8.  Anti-thymocyte globulin induces neoangiogenesis and preserves cardiac function after experimental myocardial infarction.

Authors:  Michael Lichtenauer; Michael Mildner; Gregor Werba; Lucian Beer; Konrad Hoetzenecker; Andrea Baumgartner; Matthias Hasun; Stefanie Nickl; Andreas Mitterbauer; Matthias Zimmermann; Mariann Gyöngyösi; Bruno Karl Podesser; Walter Klepetko; Hendrik Jan Ankersmit
Journal:  PLoS One       Date:  2012-12-20       Impact factor: 3.240

9.  Controlled intramyocardial release of engineered chemokines by biodegradable hydrogels as a treatment approach of myocardial infarction.

Authors:  Delia Projahn; Sakine Simsekyilmaz; Smriti Singh; Isabella Kanzler; Birgit K Kramp; Marcella Langer; Alexandrina Burlacu; Jürgen Bernhagen; Doris Klee; Alma Zernecke; Tilman M Hackeng; Jürgen Groll; Christian Weber; Elisa A Liehn; Rory R Koenen
Journal:  J Cell Mol Med       Date:  2014-02-06       Impact factor: 5.310

10.  Cytoglobin Promotes Cardiac Progenitor Cell Survival against Oxidative Stress via the Upregulation of the NFκB/iNOS Signal Pathway and Nitric Oxide Production.

Authors:  Shuning Zhang; Xiuchun Li; Frances L Jourd'heuil; Shunlin Qu; Neil Devejian; Edward Bennett; David Jourd'heuil; Chuanxi Cai
Journal:  Sci Rep       Date:  2017-09-07       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.